BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12692383)

  • 1. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum.
    Arai Y; Kusakabe H; Kiyokane K
    J Dermatol; 2003 Feb; 30(2):146-50. PubMed ID: 12692383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma arising from a syringocystadenoma papilliferum in a nevus sebaceus of Jadassohn.
    Hügel H; Requena L
    Am J Dermatopathol; 2003 Dec; 25(6):490-3. PubMed ID: 14631190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringocystadenocarcinoma papilliferum: a case report.
    Park SH; Shin YM; Shin DH; Choi JS; Kim KH
    J Korean Med Sci; 2007 Aug; 22(4):762-5. PubMed ID: 17728526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringocystadenoma papilliferum associated with apocrine poroma.
    Suzuki T; Ikeda H; Hamasaki Y; Hatamochi A; Yamazaki S
    J Dermatol; 2006 Apr; 33(4):249-51. PubMed ID: 16674787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syringocystadenocarcinoma papilliferum in situ of the penis.
    Plant MA; Sade S; Hong C; Ghazarian DM
    Eur J Dermatol; 2012; 22(3):405-6. PubMed ID: 22510243
    [No Abstract]   [Full Text] [Related]  

  • 7. A Histological Snapshot of Hypothetical Multistep Progression From Nevus Sebaceus to Invasive Syringocystadenocarcinoma Papilliferum.
    Parekh V; Guerrero CE; Knapp CF; Elmets CA; McKay KM
    Am J Dermatopathol; 2016 Jan; 38(1):56-62. PubMed ID: 26317389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear syringocystadenoma papilliferum on the retroauricular area associated with nevus sebaceus.
    Ekinci AP; Buyukbabani N; Mehdi L; Yazganoglu KD; Baykal C
    Dermatol Online J; 2016 Nov; 22(11):. PubMed ID: 28329571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare tumor: syringocystadenocarcinoma papilliferum.
    Aydin OE; Sahin B; Ozkan HS; Gore O
    Dermatol Surg; 2011 Feb; 37(2):271-4. PubMed ID: 21324034
    [No Abstract]   [Full Text] [Related]  

  • 10. Syringocystadenocarcinoma papilliferum in situ originating from the perianal skin.
    Langner C; Ott A
    APMIS; 2009 Feb; 117(2):148-50. PubMed ID: 19239438
    [No Abstract]   [Full Text] [Related]  

  • 11. Syringocystadenocarcinoma papilliferum in situ with pagetoid spread: a case report.
    Woestenborghs H; Van Eyken P; Dans A
    Histopathology; 2006 Jun; 48(7):869-70. PubMed ID: 16722938
    [No Abstract]   [Full Text] [Related]  

  • 12. Dermoscopic aspects of syringocystadenoma papilliferum associated with nevus sebaceus.
    Bruno CB; Cordeiro FN; Soares Fdo E; Takano GH; Mendes LS
    An Bras Dermatol; 2011; 86(6):1213-6. PubMed ID: 22281917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringocysadenoma papilliferum of the vulva: a rarity in gynaecology.
    Steshenko O; Chandrasekaran N; Lawton F
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24872485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus.
    Premalata CS; Kumar RV; Malathi M; Shenoy AM; Nanjundappa N
    Int J Dermatol; 2007 Mar; 46(3):306-8. PubMed ID: 17343592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syringocystadenoma papilliferum of the eyelid.
    Barbarino S; McCormick SA; Lauer SA; Milman T
    Ophthalmic Plast Reconstr Surg; 2009; 25(3):185-8. PubMed ID: 19454927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringocystadenocarcinoma papilliferum with locoregional metastases.
    Satter E; Grady D; Schlocker CT
    Dermatol Online J; 2014 Apr; 20(4):22335. PubMed ID: 24746298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis.
    Arslan H; Diyarbakrl M; Batur S; Demirkesen C
    J Craniofac Surg; 2013 Jan; 24(1):e38-40. PubMed ID: 23348331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 6 cases and review of the literature.
    Kazakov DV; Requena L; Kutzner H; Fernandez-Figueras MT; Kacerovska D; Mentzel T; Schwabbauer P; Michal M
    Am J Dermatopathol; 2010 Jun; 32(4):340-7. PubMed ID: 20216201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another view regarding ductal carcinoma arising from a syringocystadenoma papilliferum in a nevus sebaceus of Jadassohn: can a dermal component of syringocystadenoma papilliferum be excluded with certainty?
    Resnik KS
    Am J Dermatopathol; 2003 Dec; 25(6):494-5; discussion 496. PubMed ID: 14631191
    [No Abstract]   [Full Text] [Related]  

  • 20. Syringocystadenoma papilliferum: Unusual location.
    Elfatoiki F; Khadir K; Ouakadi A; Azzouzi S; Bahechar N; Benchikhi H
    Dermatol Online J; 2011 Jun; 17(6):7. PubMed ID: 21696687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.